Pfizer Inc.
A maker of medicines and vaccines, Pfizer produces well-known drugs like the blood thinner Eliquis, the Prevnar pneumonia vaccines, the Covid shot Comirnaty, the antiviral Paxlovid, and cancer treatments Ibrance and Xtandi, used by patients around the world. It was founded in 1849 in Brooklyn by German cousins Charles Pfizer, a chemist, and Charles Erhart, a confectioner, who began by coating a bitter worm medicine in almond-flavored toffee candy. Its most famous discovery, the erectile-dysfunction drug Viagra, was a happy accident—originally developed as a heart medication for angina.
Granted 491.6K
Granted 122.9K
Granted 13.4K
Granted 56.9K
Granted 37.9K
Granted 56.9K
Granted 39.3K · Sold 2.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Bourla AlbertChairman & CEO, Director · 3 transactions | -57% | 394.7K | 491.6K | — | — |
| Lankler Douglas MExecutive Vice President · 3 transactions | -7.8% | 284.3K | 122.9K | — | — |
| Boshoff ChristoffelPresident, R&D · 4 transactions | -2.3% | 168.9K | 13.4K | — | — |
| Sahni PayalExecutive Vice President · 3 transactions | +71.8% | 97.4K | 56.9K | — | — |
| McDermott MichaelExecutive Vice President · 4 transactions | -2.2% | 74.3K | 37.9K | — | — |
| Fonseca LidiaExecutive Vice President · 3 transactions | -58.3% | 46.5K | 56.9K | — | — |
| Damico Jennifer B.SVP & Controller · 9 transactions | +165% | 31.4K | 39.3K | — | 2.0K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -2.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.